文献速递腹部介入MR

90Y放射栓塞对肝细胞癌及肝实质硬度的早期影响:MR弹性成像初步经验

Early effect of 90Y radioembolisation on hepatocellular carcinoma and liver parenchyma stiffness measured with MR elastography: initial experience.
PubMed 文献 · Eur Radiol · 2021-01-21

前瞻性单中心研究纳入23例拟行90Y放射栓塞的肝细胞癌患者,于基线及术后6周行MR弹性成像(MRE)测量肿瘤硬度、瘤周及远隔肝实质硬度并检测血清AFP,评估基线参数对6周和6个月疗效的预测价值;结果显示放射栓塞后肿瘤硬度及瘤周肝硬度显著升高,远隔肝硬度不变,基线肿瘤硬度、瘤周肝硬度和AFP均能预测6周完全缓解,但对6个月疗效无显著预测价值。

要点

  • 放射栓塞后6周肿瘤硬度及瘤周肝硬度较基线显著升高,远隔肝实质硬度无显著变化。
  • 基线肿瘤硬度、瘤周肝硬度和AFP对6周完全缓解有预测价值,但对6个月疗效无显著预测价值。
  • 基线肿瘤大小与基线肿瘤硬度显著相关。

关键影像表现/征象

  • MR弹性成像在17个肿瘤中技术成功,6周时分类为完全缓解7个、部分缓解4个、疾病稳定6个。
  • 放射栓塞后肿瘤硬度(p=0.016)和瘤周肝硬度(p=0.039)显著升高,远隔肿瘤肝硬度无显著变化(p=0.245)。
  • 6周达到完全缓解的患者基线肿瘤硬度显著更低(p=0.014)。
  • 基线肿瘤大小与基线肿瘤硬度显著相关。

诊断标准与关键数值

  • 基线肿瘤硬度预测6周完全缓解的AUC=0.857。
  • 基线瘤周肝硬度预测6周完全缓解的AUC=0.857。
  • 基线AFP预测6周完全缓解的AUC=0.798。
  • 基线肿瘤硬度、瘤周肝硬度和AFP对6个月客观缓解或完全缓解均非显著预测因素。
  • 治疗反应采用mRECIST于6周和6个月判定。

临床应用与阅片要点

  • 解读放射栓塞后早期MRE时,肿瘤硬度及瘤周肝硬度升高可能反映治疗效应,而远隔肝实质硬度保持稳定。
  • 基线肿瘤硬度较低、瘤周肝硬度较低及AFP较低者可能更易在6周达到完全缓解。
  • 基线肿瘤大小与肿瘤硬度相关,测量肿瘤硬度时需结合肿瘤大小综合评估。

局限性

  • 原文为初步经验(initial experience),结果需在更大规模研究中证实。
  • 原文为前瞻性单中心研究,样本量23例。
  • MR弹性成像在17个肿瘤中技术成功。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To quantify hepatocellular carcinoma (HCC) and liver parenchyma stiffness using MR elastography (MRE) and serum alpha fetoprotein (AFP), before and 6 weeks (6w) after 90Y radioembolisation (RE), and to assess the value of baseline tumour and liver stiffness (TS/LS) and AFP in predicting response at 6w and 6 months (6 m).

METHODS: Twenty-three patients (M/F 18/5, mean age 68.3 ± 9.3 years) scheduled to undergo RE were recruited into this prospective single-centre study. Patients underwent an MRI exam at baseline and 6w following RE (range 39-47 days) which included MRE using a prototype 2D EPI sequence. TS, peritumoural LS/LS remote from the tumour, tumour size, and AFP were measured at baseline and at 6w. Treatment response was determined using mRECIST at 6w and 6 m.

RESULTS: MRE was technically successful in 17 tumours which were classified at 6w as complete response (CR, n = 7), partial response (PR, n = 4), and stable disease (SD, n = 6). TS and peritumoural LS were significantly increased following RE (p = 0.016, p = 0.039, respectively), while LS remote from tumour was unchanged (p = 0.245). Baseline TS was significantly lower in patients who achieved CR at 6w (p = 0.014). Baseline TS, peritumoural LS (both AUC = 0.857), and AFP (AUC = 0.798) showed fair/excellent diagnostic performance in predicting CR at 6w, but were not significant predictors of OR or CR at 6 m.

CONCLUSION: Our initial results suggest that HCC TS and peritumoural LS increase early after RE. Baseline TS, peritumoural LS, and AFP were all significant predictors of CR to RE at 6w. These results should be confirmed in a larger study.

KEY POINTS: • Magnetic resonance elastography-derived tumour stiffness and peritumoural liver stiffness increase significantly at 6 weeks post radioembolisation whereas liver stiffness remote from the tumour is unchanged. • Baseline tumour stiffness and peritumoural liver stiffness are lower in patients who achieve complete response at 6 weeks post radioembolisation. • Baseline tumour size is significantly correlated with baseline tumour stiffness.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kennedy P, Lewis S, Bane O, et al. Early effect of 90Y radioembolisation on hepatocellular carcinoma and liver parenchyma stiffness measured with MR elastography: initial experience. Eur Radiol. 2021. PMID: 33475773. doi:10.1007/s00330-020-07636-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。